摘要:
The present invention provides a method for the diagnosis of AD from non-AD conditions by using a PKC Isozyme Index obtained by determining ratios of ratios of different PKC Isozymes in peripheral cells of a test subject in the absence and presence of a beta-amyloid peptide, and optionally, in the presence of a PKC activator.
摘要:
The present invention relates to methods of activate an isoform of protein kinase C (PKC) for the treatment of neurological diseases including Alzheimer's disease and stroke using cyclopropanated or epoxidized derivatives of mono- and polyunsaturated fatty acids. The present invention also relates to methods of reducing neurodegeneration using cyclopropanated or epoxidized derivatives of mono- and polyunsaturated fatty acids.
摘要:
A dynamically stable associative learning neural system includes a plurality of neural network architectural units. A neural network architectural unit has as input both condition stimuli and unconditioned stimulus, an output neuron for accepting the input, and patch elements interposed between each input and the output neuron. The patches in the architectural unit can be modified and added. A neural network can be formed from a single unit, a layer of units, or multiple layers of units.
摘要:
A dynamically stable associative learning neural network system includes, in its basic architectural unit, at least one each of a conditioned signal input, an unconditioned signal input and an output. Interposed between input and output elements are "patches," or storage areas of dynamic interaction between conditioned and unconditioned signals which process information to achieve associative learning locally under rules designed for application-related goals of the system. Patches may be fixed or variable in size. Adjustments to a patch radius may be by "pruning" or "budding." The neural network is taught by successive application of training sets of input signals to the input terminals until a dynamic equilibrium is reached. Enhancements and expansions of the basic unit result in multilayered (multi-subnetworked) systems having increased capabilities for complex pattern classification and feature recognition.
摘要:
A method of removing splinters and the like from the human body includes steps wherein the upper cellular layers of the skin in the area of the splinter are removed by applying substantially unidirectional shaving strokes to the area with a razor-like blade in a direction substantially opposite the direction of insertion of the splinter. After an amount of skin sufficient to expose a portion of the splinter has been removed, continued unidirectional stroking causes the blade to cut slightly into the now exposed splinter to effect the grasping thereof with the blade, whereupon the splinter is extracted by the blade. The preferred apparatus used in performing the method comprises a cutting head, a razor-like blade mounted in the cutting head and an offset handle attached to the cutting head for guiding the apparatus across the skin of a patient to effect shaving strokes in accordance with the method.
摘要:
The invention provides for the use of protein kinase activators or boosters of nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) or other neurotrophic factors to treat head trauma. Specifically, the present invention provides methods of treating head trauma comprising the steps of identifying a subject having suffered a head trauma and administering to said subject an amount of a pharmaceutical composition comprising a protein kinase C (PKC) activator or 4-methylcatechol acetic acid (MCBA) and a pharmaceutically acceptable carrier effective to treat at least one symptom of head trauma.
摘要:
The present invention relates to a method for diagnosing Alzheimer's Disease (AD) using PKC-elicited gene expression profiles. PKC-activation elicits different genomic profiles in AD cells, as compared with control cells, which can be used to diagnose AD and individuals at risk for developing AD.
摘要:
The present invention relates to methods of activate an isoform of protein kinase C (PKC) for the treatment of neurological diseases including Alzheimer's disease and stroke using cyclopropanated or epoxidized derivatives of mono- and polyunsaturated fatty acids. The present invention also relates to methods of reducing neurodegeneration using cyclopropanated or epoxidized derivatives of mono- and polyunsaturated fatty acids.
摘要:
The present invention relates to compositions comprising a combination of PKC activators and PKC inhibitors and methods to modulate α-secretase activity; improve or enhance cognitive ability; and/or reduce neurodegeneration in individuals suffering from diseases that impair cognitive ability, particularly Alzheimer's Disease. The invention also relates to methods for improving or enhancing cognitive ability. The present invention also provides methods for increasing the generation of non-amyloidogenic soluble APP (sAPP) comprising the activation of protein kinase C (PKC) in the brain and inhibiting PKC in peripheral tissues. Macrocyclic lactones (i.e. bryostatin class and neristatin class) are preferred PKC activators and Vitamin E is a preferred PKC inhibitor for use in the inventive composition.
摘要:
This invention relates to a highly efficient artificial low-density lipoprotein (LDL) carrier system for the targeted delivery therapeutic agents across the blood-brain barrier (BBB). In particular, this invention relates to artificial LDL particles comprised of three lipid elements: phosphatidyl choline, fatty-acyl-cholesterol esters, and at least one apolipoprotein. The present invention further relates to compositions, methods and kits comprising artificial LDL particles for targeting drugs to and across the BBB for the prevention and treatment of brain diseases.